FORTE BIOSCIENCES, INC.: change in accounts payable

What this measure means

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

Exact concept: us-gaap:IncreaseDecreaseInAccountsPayable. Each value covers an annual-duration reporting interval, shown with both start and end dates. Different units remain separate; no currency conversion or interpolation is applied.

Coverage of this history

Selected reporting periods run from 2015-01-01 to 2025-12-31. The SEC response was captured on 2026-09-21.

Selected filing history

Related financial histories

• FORTE BIOSCIENCES, INC.: total assets
• FORTE BIOSCIENCES, INC.: total liabilities
• FORTE BIOSCIENCES, INC.: stockholders equity
• FORTE BIOSCIENCES, INC.: cash and cash equivalents
• FORTE BIOSCIENCES, INC.: net income or loss
• FORTE BIOSCIENCES, INC.: operating cash flow
• FORTE BIOSCIENCES, INC.: capital expenditure payments
• FORTE BIOSCIENCES, INC.: contract revenue excluding tax
• FORTE BIOSCIENCES, INC.: financing cash flow
• FORTE BIOSCIENCES, INC.: investing cash flow
• FORTE BIOSCIENCES, INC.: retained earnings or deficit
• FORTE BIOSCIENCES, INC.: basic earnings per share
• FORTE BIOSCIENCES, INC.: diluted earnings per share
• FORTE BIOSCIENCES, INC.: income tax expense or benefit
• FORTE BIOSCIENCES, INC.: net property, plant and equipment
• FORTE BIOSCIENCES, INC.: share-based compensation expense
• FORTE BIOSCIENCES, INC.: operating income or loss
• FORTE BIOSCIENCES, INC.: current assets
• FORTE BIOSCIENCES, INC.: current liabilities
• FORTE BIOSCIENCES, INC.: current accounts payable
• FORTE BIOSCIENCES, INC.: operating expenses
• FORTE BIOSCIENCES, INC.: research and development expense
• FORTE BIOSCIENCES, INC.: common shares outstanding
• FORTE BIOSCIENCES, INC.: cash including restricted cash
• FORTE BIOSCIENCES, INC.: accumulated other comprehensive income or loss
• FORTE BIOSCIENCES, INC.: gross property, plant and equipment
• FORTE BIOSCIENCES, INC.: accumulated depreciation on property, plant and equipment
• FORTE BIOSCIENCES, INC.: other noncurrent assets
• FORTE BIOSCIENCES, INC.: accrued current liabilities
• FORTE BIOSCIENCES, INC.: prepaid expenses and other current assets
• FORTE BIOSCIENCES, INC.: pre-tax income or loss from continuing operations
• FORTE BIOSCIENCES, INC.: comprehensive income or loss
• FORTE BIOSCIENCES, INC.: general and administrative expense
• FORTE BIOSCIENCES, INC.: depreciation expense
• FORTE BIOSCIENCES, INC.: other nonoperating income or expense
• FORTE BIOSCIENCES, INC.: nonoperating income or expense
• FORTE BIOSCIENCES, INC.: current income tax expense or benefit
• FORTE BIOSCIENCES, INC.: interest paid, net
• FORTE BIOSCIENCES, INC.: proceeds from issuing common stock

Inspect the source

Entity

FORTE BIOSCIENCES, INC. / CIK 0001419041

Captured

2026-09-21T17:19:39.377Z

SEC response SHA-256

97a8cfde84ea5a1e6e1cc5bf6c43c7b79aff3db0e95d5360fc3b1b4c3b567812

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Latest-filed annual-report facts per unit and reporting period at capture time. Duration facts cover 300 to 400 days. This selection can include restatements and is not a point-in-time backtest dataset. Missing concepts are omitted, never zero-filled. Values retain original units and are not currency converted. Extended concepts require compatible unit shapes and at least three reporting ends with changing values within one unit. Constant or incompatible added histories are omitted.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

• Get an API key and run your first validation
• Connect the MCP server to your coding assistant
• Inspect the ALPHAC engine on GitHub
• Read the MCP server source and integration examples

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001419041.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))